Skip to Main Content

Paper Details

Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Clin J Am Soc Nephrol
23
2020
Author NameAffiliation
Olivier DevuystInstitute of Physiology, University of Zurich
Olivier DevuystUniversite Catholique de Louvain Medical School
  • 1 - 2

Datasets

Release 1.2